ABOUT IMP

Shawn H. Zimberg, MD

Director of Radiation Oncology Services

Dr. Zimberg is board-certified in Radiation Oncology and has additional experience in investment banking. In the NY metropolitan area, he is recognized as a leader in the treatment of prostate, breast and head & neck cancers.

He completed his residency at Memorial Sloan-Kettering Cancer Center, where he was awarded the American Cancer Society’s Clinical Oncology Fellowship. More recently, he was the recipient of the American Cancer Society’s Cancer Control Award and currently serves on their Eastern Division’s Advisory Board, where he held the position of Medical Spokesman from 2004-2006.

Dr. Zimberg is a principal in Foundation Ventures, LLC, a NYC investment and merchant banking firm, where he is currently serving on their Health Science Advisory Board. Prior to residency, Dr. Zimberg was a medical advisor to Advanced Capital Resources, a private banking concern, where he specialized in medical device and biotechnology sectors. Following his residency, he has been involved in private banking and financings for biotechnology companies.

Dr. Zimberg received both his undergraduate and M.D. degrees from the University of Michigan, Ann Arbor.

 

 

 

 

 

 

 

 

 

 

 

IMP’s Management Team:
Deepak A. Kapoor, MD
Chairman and CEO
W. Price Dunaway
Chief Operating Officer
Carl A. Olsson, MD
Chief Medical Officer
Kathleen L. Latino, MD, FACS
Medical Director
Shawn H. Zimberg, MD
Director of Radiation Oncology Services
Ann E. Anderson, MD
Director of Pathology
Toni Rawlings, CPA
Director of Finance
Karen Hohlman
Director of Operations
Randi Pincus
Director of Marketing
Jonathan Anderson
Director of Laboratory Operations